|
2006P-0422:
Refrain from Approval of any Abbreviated New Drug Application (ANDA)
for Metoprolol Succinate Extended Release 100 mg and 200 mg Tablets
Subsequent to ANDA 76-640 from KV Pharmaceutical
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
| |
CP1 |
|
10/18/2006
|
|
10/18/2006
|
|
Private Industry
|
|
KV Pharmaceutical
Company |
|
|
|
|
|
|
|
Table
of Contents |
|
|
|
| |
Signature: |
|
Charles A. Weiss
|
|
| |
| |
ACK1 |
|
10/18/2006
|
|
10/18/2006
|
|
Federal Government |
|
FDA/ DDM to
KV Pharmaceutical Company |
|
|
|
|
|
|
|
pdf |
|
|
|
| |
|
|
Signature: |
|
Jennie C. Butler
|
|
|
|
| CR1
|
| 10/23/2006
|
| 10/23/2006
|
| Federal Government
|
| FDA/DDM to KV Pharmaceutical
Co.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jennie Butler
| |
|
|
| LET1
|
| 04/16/2007
|
| 04/11/2007
|
| Federal Government
|
| FDA/CDER to KV Pharmaceutical
Co
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
| |
|
Top | Up Page last updated:
April 18, 2007
|
